Bausch + Lomb Corporation (BLCO) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↑
17.56
+1% vs avg
5yr avg: 17.40
30Y Low13.0·High20.2
P/FCF
N/A
—
5yr avg: 31.93
30Y Low31.9·High31.9
P/B Ratio
↑
0.87
-1% vs avg
5yr avg: 0.88
30Y Low0.8·High1.0
ROE
↓
-5.5%
↑-130% vs avg
5yr avg: -2.4%
30Y Low-6%·High3%
Debt/EBITDA
↑
8.82
↑+43% vs avg
5yr avg: 6.15
30Y Low0.1·High9.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
BLCO Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Bausch + Lomb Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $5.7B | $6.0B | $6.4B | $6.0B | $5.4B | — | — | — |
| Enterprise Value | $10.7B | $11.0B | $11.0B | $10.3B | $7.6B | — | — | — |
| P/E Ratio → | -15.69 | — | — | — | 361.54 | — | — | — |
| P/S Ratio | 1.12 | 1.18 | 1.33 | 1.44 | 1.44 | — | — | — |
| P/B Ratio | 0.87 | 0.93 | 0.97 | 0.86 | 0.76 | — | — | — |
| P/FCF | — | — | — | — | 31.93 | — | — | — |
| P/OCF | 20.16 | 21.35 | 27.39 | — | 15.73 | — | — | — |
P/E links to full P/E history page with 30-year chart
BLCO EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Bausch + Lomb Corporation's enterprise value stands at 17.6x EBITDA, roughly in line with its 5-year average of 17.4x. The Healthcare sector median is 14.0x, placing the stock at a 25% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.16 | 2.29 | 2.49 | 2.02 | — | — | — |
| EV / EBITDA | 17.56 | 18.11 | 18.37 | 20.16 | 12.97 | — | — | — |
| EV / EBIT | 56.87 | 58.67 | 66.57 | 88.22 | 34.71 | — | — | — |
| EV / FCF | — | — | — | — | 44.72 | — | — | — |
BLCO Profitability
Margins and return-on-capital ratios measuring operating efficiency
Bausch + Lomb Corporation earns an operating margin of 3.7%. A negative ROE of -5.5% indicates the company is currently destroying shareholder equity. ROIC of 1.2% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.8% | 54.8% | 60.9% | 60.4% | 59.7% | 61.0% | 62.3% | 64.9% |
| Operating Margin | 3.7% | 3.7% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% | 10.5% |
| Net Profit Margin | -7.1% | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% | 7.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -5.5% | -5.5% | -4.7% | -3.7% | 0.1% | 1.9% | -0.2% | 3.0% |
| ROA | -2.6% | -2.6% | -2.4% | -2.1% | 0.1% | 1.6% | -0.2% | 2.6% |
| ROIC | 1.2% | 1.2% | 1.1% | 0.9% | 1.7% | 2.6% | 2.0% | 3.0% |
| ROCE | 1.6% | 1.6% | 1.4% | 1.2% | 2.1% | 3.3% | 2.5% | 3.8% |
BLCO Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Bausch + Lomb Corporation carries a Debt/EBITDA ratio of 8.8x, which is highly leveraged (182% above the sector average of 3.1x). Net debt stands at $5.0B ($5.4B total debt minus $383M cash). Interest coverage of just 0.4x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | 0.75 | 0.68 | 0.36 | 0.01 | 0.01 | 0.01 |
| Debt / EBITDA | 8.82 | 8.82 | 8.25 | 9.13 | 4.36 | 0.19 | 0.14 | 0.11 |
| Net Debt / Equity | — | 0.76 | 0.71 | 0.63 | 0.31 | -0.00 | -0.01 | -0.01 |
| Net Debt / EBITDA | 8.19 | 8.19 | 7.74 | 8.48 | 3.71 | -0.05 | -0.20 | -0.11 |
| Debt / FCF | — | — | — | — | 12.79 | -0.05 | -0.52 | -0.16 |
| Interest Coverage | 0.44 | 0.44 | 0.41 | 0.41 | 1.50 | — | — | — |
BLCO Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.55x means Bausch + Lomb Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.04x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.74x to 1.55x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 | 1.82 | 1.64 |
| Quick Ratio | 1.04 | 1.04 | 1.01 | 1.09 | 1.16 | 0.97 | 1.14 | 1.07 |
| Cash Ratio | 0.20 | 0.20 | 0.18 | 0.21 | 0.29 | 0.16 | 0.26 | 0.19 |
| Asset Turnover | — | 0.36 | 0.36 | 0.31 | 0.34 | 0.35 | 0.30 | 0.33 |
| Inventory Turnover | 2.36 | 2.36 | 1.81 | 1.60 | 2.42 | 2.56 | 2.09 | 2.24 |
| Days Sales Outstanding | — | 87.37 | 78.17 | 77.03 | 70.33 | 69.90 | 69.00 | 68.88 |
BLCO Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Bausch + Lomb Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 0.3% | — | — | — |
| FCF Yield | — | — | — | — | 3.1% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $354M | $352M | $351M | $350M | $350M | $350M | $350M |
Peer Comparison
Compare BLCO with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 BLCOYou | $6B | -15.7 | 17.6 | — | 54.8% | 3.7% | -5.5% | 1.2% | 8.8 |
 HSIC | $9B | 22.7 | 11.3 | 14.9 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 |
 ATRC | $1B | -122.7 | 82.6 | 30.9 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 LNTH | $6B | 25.2 | 13.7 | 15.8 | 61.1% | 20.2% | 21.4% | 30.6% | 0.0 |
 JNJ | $544B | 39.0 | 18.9 | 27.4 | 69.1% | 24.9% | 20.1% | 20.7% | 1.2 |
 ABT | $152B | 11.4 | 15.9 | 23.9 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 COO | $12B | 32.8 | 13.3 | 27.7 | 60.7% | 16.7% | 4.6% | 4.8% | 2.5 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 IART | $1B | -2.0 | 12.9 | — | 51.7% | 4.2% | -39.9% | 1.7% | 9.3 |
 ALGN | $12B | 29.9 | 14.0 | 24.6 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 |
 BHC | $2B | 13.1 | 6.4 | 2.1 | 60.9% | 21.3% | 588.2% | 8.2% | 6.1 |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See BLCO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BLCO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BLCO vs HSIC
Side-by-side business, growth, and profitability comparison vs Henry Schein, Inc..
Start ComparisonBLCO — Frequently Asked Questions
Quick answers to the most common questions about buying BLCO stock.
What is Bausch + Lomb Corporation's P/E ratio?
Bausch + Lomb Corporation's current P/E ratio is -15.7x. This places it at the 50th percentile of its historical range.
What is Bausch + Lomb Corporation's EV/EBITDA?
Bausch + Lomb Corporation's current EV/EBITDA is 17.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.4x.
What is Bausch + Lomb Corporation's ROE?
Bausch + Lomb Corporation's return on equity (ROE) is -5.5%. The historical average is -1.3%.
Is BLCO stock overvalued?
Based on historical data, Bausch + Lomb Corporation is trading at a P/E of -15.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Bausch + Lomb Corporation's profit margins?
Bausch + Lomb Corporation has 54.8% gross margin and 3.7% operating margin.
How much debt does Bausch + Lomb Corporation have?
Bausch + Lomb Corporation's Debt/EBITDA ratio is 8.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.